Reproductive factors and risk of luminal, HER2-overexpressing, and triple-negative breast cancer among multiethnic women

Cancer Epidemiology Biomarkers and Prevention

Volumn 25, Issue 9, 2016, Pages 1297-1304

  Chen, Lu ^a   Li, Christopher I ^a   Tang, Mei Tzu C ^a   Porter, Peggy ^a   Hill, Deirdre A ^b   Wiggins, Charles L ^b   Cook, Linda S ^b  

^a USA   (United States)

^b UNIVERSITY OF NEW MEXICO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN; ESTROGEN RECEPTOR; GESTAGEN; ORAL CONTRACEPTIVE AGENT; PROGESTERONE RECEPTOR; MEMBRANE PROTEIN; TUMOR MARKER;

ADULT; AFRICAN AMERICAN; AGED; ALASKA NATIVE; AMERICAN INDIAN; ARTICLE; BREAST FEEDING; CANCER RISK; CAUCASIAN; DISEASE ASSOCIATION; ETHNICITY; FEMALE; HISPANIC; HUMAN; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; MENARCHE; MENOPAUSE; NEW MEXICO; NULLIPARA; PACIFIC ISLANDER; PARITY; PREGNANCY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REPRODUCTION; TRIPLE NEGATIVE BREAST CANCER; BLOOD; CANCER REGISTRY; CASE CONTROL STUDY; EPIDEMIOLOGY; ETHNOLOGY; HEALTH SURVEY; INCIDENCE; METABOLISM; MIDDLE AGED; PHYSIOLOGY; RISK FACTOR; STATISTICS AND NUMERICAL DATA; WASHINGTON; YOUNG ADULT;

ADULT; AFRICAN AMERICANS; AGED; BIOMARKERS, TUMOR; CASE-CONTROL STUDIES; FEMALE; HISPANIC AMERICANS; HUMANS; INCIDENCE; MEMBRANE GLYCOPROTEINS; MENOPAUSE; MIDDLE AGED; NEW MEXICO; PARITY; POPULATION SURVEILLANCE; PREGNANCY; RECEPTOR, ERBB-2; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; RISK FACTORS; SEER PROGRAM; TRIPLE NEGATIVE BREAST NEOPLASMS; WASHINGTON; YOUNG ADULT;

EID: 84986212341     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-15-1104     Document Type: Article

References (35)

1. Clavel-Chapelon F, Gerber M. Reproductive factors and breast cancer risk. Do they differ according to age at diagnosis? Breast Cancer Res Treat 2002;72:107-15.
2. Collaborative Group on Hormonal Factors in Breast Cancer. Breast cancer and breastfeeding: collaborative reanalysis of individual data from 47 epidemiological studies in 30 countries, including 50302womenwith breast cancer and 96973 women without the disease. Lancet 2002;360:187-95.
3. Perou CM, Sørlie T, Eisen MB, van de Rijn M, Jeffrey SS, Rees CA, et al. Molecular portraits of human breast tumours. Nature 2000;406:747-52.
4. Sorlie T, Tibshirani R, Parker J, Hastie T, Marron JS, Nobel A, et al. Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc Natl Acad Sci U S A 2003;100:8418-23.
5. Carey LA, Perou CM, Livasy CA, Dressler LG, Cowan D, Conway K, et al. Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. JAMA 2006;295:2492-502.
6. Onitilo AA, Engel JM, Greenlee RT, Mukesh BN. Breast cancer subtypes based on ER/PR and Her2 expression: comparison of clinicopathologic features and survival. Clin Med Res 2009;7:4-13.
7. Dawood S, Hu R, Homes MD, Collins LC, Schnitt SJ, Connolly J, et al. Defining breast cancer prognosis based on molecular phenotypes: results from a large cohort study. Breast Cancer Res Treat 2011;126:185-92.
8. Kelsey JL, Gammon MD, John EM. Reproductive factors and breast cancer. Epidemiol Rev 1993;15:36-47.
9. Bernstein L, Ross RK. Endogenous hormones and breast cancer risk. Epidemiol Rev 1993;15:48-65.
10. Ma H, Bernstein L, Pike MC, Ursin G. Reproductive factors and breast cancer risk according to joint estrogen and progesterone receptor status: a meta-analysis of epidemiological studies. Breast Cancer Res 2006;8: R43.
11. MaH, Henderson KD, Sullivan-Halley J, Duan L,Marshall SF, Ursin G, et al. Pregnancy-related factors and the risk of breast carcinoma in situ and invasive breast cancer among postmenopausal women in the California Teachers Study cohort. Breast Cancer Res 2010;12:R35.
12. Phipps AI, Malone KE, Porter PL, Daling JR, Li CI. Reproductive and hormonal risk factors for postmenopausal luminal, HER-2-overexpressing, and triple-negative breast cancer. Cancer 2008;113:1521-6.
13. Setiawan VW, Monroe KR, Wilkens LR, Kolonel LN, Pike MC, Henderson BE. Breast cancer risk factors defined by estrogen and progesterone receptor status: themultiethnic cohort study. AmJ Epidemiol 2009;169: 1251-9.
14. Lund MJ, Trivers KF, Porter PL, Coates RJ, Leyland-Jones B, Brawley OW, et al. Race and triple negative threats to breast cancer survival: a populationbased study in Atlanta, GA. Breast Cancer Res Treat 2009;113:357-70.
15. Millikan RC, Newman B, Tse CK, Moorman PG, Conway K, Smith LV, et al. Epidemiology of basal-like breast cancer. Breast Cancer Res Treat 2008;109:123-39.
16. Gaudet MM, Press MF, Haile RW, Lynch CF, Glaser SL, Schildkraut J, et al. Risk factors by molecular subtypes of breast cancer across a populationbased study of women 56 years or younger. Breast Cancer Res Treat 2011;130:587-97.
17. Yang XR, Sherman ME, Rimm DL, Lissowska J, Brinton La, Peplonska B, et al. Differences in risk factors for breast cancer molecular subtypes in a population-based study. Cancer Epidemiol Biomarkers Prev 2007;16: 439-43.
18. Tamimi RM, Colditz G a, Hazra A, Baer HJ, Hankinson SE, Rosner B, et al. Traditional breast cancer risk factors in relation to molecular subtypes of breast cancer. Breast Cancer Res Treat 2012;131:159-67.
19. Li CI, Beaber EF, Tang M-TC, Porter PL, Daling JR, Malone KE. Reproductive factors and risk of estrogen receptor positive, triple-negative, and HER2-neu overexpressing breast cancer among women 20-44 years of age. Breast Cancer Res Treat 2013;137:579-87.
20. Phipps AI, Chlebowski RT, Prentice R, McTiernan A, Wactawski-Wende J, Kuller LH, et al. Reproductive history and oral contraceptive use in relation to risk of triple-negative breast cancer. J Natl Cancer Inst 2011; 103:470-7.
21. Phipps AI, Buist DSM, Malone KE, Barlow WE, Porter PL, Kerlikowske K, et al. Reproductive history and risk of three breast cancer subtypes defined by three biomarkers. Cancer Causes Control 2011;22:399-405.
22. Palmer JR, Viscidi E, Troester MA, Hong C-C, Schedin P, Bethea TN, et al. Parity, lactation, and breast cancer subtypes in African American women: results from the AMBER Consortium. J Natl Cancer Inst 2014;106:pii: dju237.
23. Ambrosone CB, ZirpoliG, Hong C-C, Yao S, Troester MA, Bandera E V, et al. Important role of menarche in development of estrogen receptor-negative breast cancer in African American women. J Natl Cancer Inst 2015;107:pii: djv172.
24. Howlader N, Altekruse SF, Li CI, Chen VW, Clarke C a, Ries LAG, et al. US incidence of breast cancer subtypes defined by joint hormone receptor and HER2 status. J Natl Cancer Inst. 2014;106:pii:dju055.
25. Martinez ME, Wertheim BC, Natarajan L, Schwab R, Bondy M, Daneri-Navarro A, et al. Reproductive factors, heterogeneity, and breast tumor subtypes inwomenof mexican descent. Cancer Epidemiol Biomarkers Prev 2013;22:1853-61.
26. Martin JA,Hamilton B,Osterman M, Curtin S,Mathews T. Births: final data for2013. [cited 2015 Oct 13]. Hyattsville, MD. Available form:http://www. cdc.gov/nchs/data/nvsr/nvsr64/nvsr64-01.pdf.
27. Li CI, Beaber EF, Tang MTC, Porter PL, Daling JR,Malone KE, et al. Effect of depo-medroxyprogesterone acetate on breast cancer risk among women 20 to 44 years of age. Cancer Res 2012;72:2028-35.
28. Li CI, Malone KE, Porter PL, Lawton TJ, Voigt LF, Cushing-Haugen KL, et al. Relationship between menopausal hormone therapy and risk of ductal, lobular, and ductal-lobular breast carcinomas. Cancer Epidemiol Biomarkers Prev 2008;17:43-50.
29. Trivers KF, Lund MJ, Porter PL, Liff JM, Flagg EW, Coates RJ, et al. The epidemiology of triple-negative breast cancer, including race. Cancer Causes Control 2009;20:1071-82.
30. Ambrosone CB, Zirpoli G, Ruszczyk M, Shankar J, Hong C-C, McIlwain D, et al. Parity and breastfeeding among African-American women: differential effects on breast cancer risk by estrogen receptor status in the Women's Circle of Health Study. Cancer Causes Control 2014;25:259-65.
31. Li CI, Malone KE, Daling JR, Potter JD, Bernstein L, Marchbanks P a, et al. Timing of Menarche and First Full-Term Birth in Relation to Breast Cancer Risk. Am J Epidemiol 2007;167:230-9.
32. Bernier MO. Breastfeeding and risk of breast cancer: a meta-analysis of published studies. Hum Reprod Update 2000;6:374-86.
33. Lipworth L, Bailey LR, Trichopoulos D. History of breast-feeding in relation to breast cancer risk: a review of the epidemiologic literature. J Natl Cancer Inst 2000;92:302-12.
34. Bauer KR, Brown M, Cress RD, Parise CA, Caggiano V. Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype: a population-based study from the California cancer Registry. Cancer 2007;109:1721-8.
35. Centers for Disease Control and Prevention (CDC). Progress in increasing breastfeeding and reducing racial/ethnic differences-United States, 2000-2008 births. MMWR Morb Mortal Wkly Rep 2013;62:77-80.